Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 15 of 15 for “"PIK3CA gene"”.
-
Mελέτη της ενεργοποίησης του κυτταρικού μονοπατιού PI3K/Akt στο λέμφωμα μανδύα
… (mTOR) signaling are implicated in the pathogenesis of mantle cell lymphoma (MCL). In this study, 35 tissue samples from primary MCL cases and 2 MCL cell lines (Granta-519 and Rec-1) were used to investigate the PI3K/Akt signaling pathway. The aims of the study were: a) Το study the …
-
Μελέτη μορίων που εμπλέκονται στα μονοπάτια σηματοδότησης PI3K/AKT/mTOR και RAS/RAF/MEK/ERK σε αστροκυτώματα
… G protein-coupled receptors (GPCRs) and oncogenes such as Ras PI3K phosphorylates PIP2 to PIP3 which activates downstream effector molecules such as AKT AKT functions through its ability to phosphorylate a number of key pro oncogenic targets that promote cell growth or inhibit apoptotic …
-
The prognostic utility of perioperative blood-based liquid biopsy, inflammatory and tumour biomarkers in patients with non-metastatic breast cancer
… quantified. Circulating tumour DNA (ctDNA) with PIK3CA gene mutation was detected using HRM PCR and Allele specific fluorescence probe-based PCR. Systemic inflammatory mediators and the tumour marker CA 15-3 were detected using ELISA kit. Results: In the cohort of 62 patients (age, median (IQR), …
-
Μοριακή μελέτη σηματοδοτικών μονοπατιών στην καρκινογένεση
… such as proliferation and migration, morphogenesis and planar cell polarity. In the mammary gland, Wnt signals are strongly implicated in initial development of the mammary rudiments, and in the ductal branching and alveolar morphogenesis that occurs during pregnancy. In addition crosstalk …
-
Detection of PIK3CA Mutations in Plasma Tumor DNA Circulating in Peripheral Blood of Breast Cancer Patients
Tumor-specific mutations are used as genetic biomarkers for breast cancer diagnosis and prognosis. The detection and quantification of mutations in tumor DNA circulating in peripheral blood offers a non-invasive approach for measuring the presence of cancer in patients and for evaluating individual …
-
Μεταλλάξεις και πολυμορφισμοί στα εξόνια 1 και 2 του γονιδίου HRAS και στο εξόνιο 15 του γονιδίου BRAF σε πάσχοντες από ακανθοκυτταρικό καρκίνωμα της στοματικής κοιλότητας στον ελληνικό πληθυσμό
… we have previously detected absence of hotspot PIK3CA gene mutations in the Greek population, we hypothesized that the HRAS might be activated as upstream effector of the pathway. Furthermore, the status of the BRAF mutations in OSCC has never been assessed before in the Greek population. Eighty …
-
Desarrollo de métodos integrados para la determinación de biomarcadores genéticos
… for detection of point mutations in the PIK3CA, KRAS and BRAF genes associated with colorectal cancer. These predictive biomarkers are related to increased cell proliferation, apoptosis, and resistance to monoclonal antibody treatments (Cetuximab and Panitumumab). Isothermal DNA …
-
Einfluss der mRNA-Expression der EGFR-Liganden Epiregulin (EREG) und Amphiregulin (AREG) auf das Überleben von Patienten mit metasta-siertem kolorektalen Karzinom unter 5-Fluoruracil/Leucovorin plus Irino-tecan (FUFIRI) oder Irinotecan plus Oxaliplatin Erstlinientherapie (FIRE 1 – Studie)
… der Mutationsstatus für die Proteine RAS und PIK3CA unter Verwendung der Py-osequenzierung erhoben. Das Kollektiv basierte auf der FIRE1-Studie und bestand aus 208 Patienten mit metastasiertem kolorektalen Karzinom unter 5-Fluoruracil / Leucovorin / Irinotecan – Therapie (FUFIRI) oder unter …
-
Οι μεταλλάξεις και οι πολυμορφισμοί των εξονίων 9 και 20 του γονιδίου PIK3CA σε πάσχοντες από ακανθοκυτταρικό καρκίνωμα του βλεννογόνου του στόματος
… mortality worldwide (2). Oral carcinogenesis is considered to involve progressive accumulation of genetic alterations, although up to date, the underlying genetic mechanisms remain unclear and complex (123). Phosphatidylinositol-3 kinases (PI3Ks) constitute a large family of …
-
Defining the molecular mechanisms mediating class IA phosphoinositide 3-kinase (PI3K) regulation and their role in human disease
… of PIP3 production. Activating mutations in the genes encoding the catalytic and regulatory subunits of PI3K lead to cancer and immunodeficiencies. The PIK3CA gene encoding the p110 catalytic subunit of class IA PI3K is one of the most frequently mutated genes in cancer, and mutations in the …
-
Υγρή βιοψία-μοριακή διάγνωση καρκίνου: ανάπτυξη μεθόδων ανάλυσης κυκλοφορούντων καρκινικών κυττάρων και αντίστοιχου ctDNA και κλινική αξιολόγηση της ετερογένειάς τους στον καρκίνο μαστού
… the various mechanisms underlying the heterogeneity of cancer cells within the patient as well as those of tumor progression. The detection of mutations in liquid biopsy samples (ctDNA and CTCs) requires highly sensitive techniques due to the low frequency of mutated alleles in the total …
-
Στοχευμένα φάρμακα: ενδοκυττάρωση, διακίνηση και μοριακός μηχανισμός δράσης: ταυτοποίηση και λειτουργικός χαρακτηρισμός ρυθμιστών της αγγειογένεσης σε καρκινικά κύτταρα του παχέος εντέρου που φέρουν μεταλλάξεις στο γονίδιο PIK3CA
… progression. In 10-30% of colon cancers the oncogene PIK3CA, which encodes the catalytic subunit of PI3Ks (p110α), is mutated and has been studied as an effective molecular target for therapeutic interventions. The most common mutations of the PIK3CA gene in colon cancer are H1047R, in the kinase …
-
Cooperative regulation of autophagy by oncogenic PI3-kinase and NRF2 signaling pathways
… from upper bronchial airway epithelium. The gene mutations from premalignant tumors are thought to initiate neoplasia but cannot promote malignancy independently. It is hypothesized that additional cooperating mutations will have a compounding effect on tumorigenesis if co-expressed in the …
-
Využití molekulárně-genetických metod při výzkumu kolorektálního karcinomu
Cílem této bakalářské práce je analýza mutací v genech KRAS, BRAF a PIK3CA. Úvodní část je věnována kolorektálnímu karcinomu obecně. Následující části se zabývají úvodem do genetiky zhoubného bujení, popisem genů, které hrají u kolorektálního karcinomu důležitou roli (KRAS, BRAF a PIK3CA), …